| GlaxoSmithKline AG - Fluarix Tetra 15 µg / 0.5 ml, Injektionssuspension | | 62961 | | 08 | | Fluarix Tetra 15 µg / 0.5 ml | | Injektionssuspension | | J07BB02 | | Influenza, gereinigtes Antigen | | 11.08.2021 | | |
| | Zusammensetzung | | haemagglutininum influenzae A (H1N1) (Virus Stamm A/Victoria/2570/2019 (H1N1)-like: reassortant virus IVR-215 derived from A/Victoria/2570/2019) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Cambodia/e0826360/2020 (H3N2)-like: reassortant virus IVR-221 derived from A/Tasmania/503/2020) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Washington/02/2019-like: reassortant virus B/Washington/02/2019 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alpha-tocopheroli hydrogenosuccinas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: ovalbuminum, formaldehydum, natrii desoxycholas, gentamicini sulfas, hydrocortisonum. | | Packungsbestandteile | | | | | | | | | | Wirkstoffe | Stärke |
|---|
| | 15µg / 0.5ml | | | 15µg / 0.5ml | | | 15µg / 0.5ml |
| | BAG: Wirkstoffe | Stärke |
|---|
| Influenza-hämagglutinin | 60 mcg |
| | | | Hilfsstoffe | Stärke |
|---|
| | | | Dinatrii Phosphas Dodecahydricus | | | | 15µg / 0.5ml | | Kalii Chloridum | | | Kalii Dihydrogenophosphas | | | Magnesii Chloridum Hexahydricum | | | Natrii Chloridum | | | | | | Polysorbatum 80 | |
| |
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| Es wurden keine Einträge gefunden. |
|
|
